FDA Approved: BUDESONIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for budesonide. The action reflects changes to the product's labeling or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma
• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Budesonide (BUDESONIDE)

Snippet

SUPPL AP for BUDESONIDE (BUDESONIDE)